Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy.
about
Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutionsAnti-Immune Strategies of Pathogenic FungiThe Cryptococcus neoformans capsule: lessons from the use of optical tweezers and other biophysical toolsAntibody-mediated immobilization of Cryptococcus neoformans promotes biofilm formation.Antibody binding to Cryptococcus neoformans impairs budding by altering capsular mechanical properties.Pathogenesis of mucosal biofilm infections: challenges and progress.Antigenic and phenotypic variations in fungiAb binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism.Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitroAntibody-guided alpha radiation effectively damages fungal biofilmsMedical biofilms.Biofilm formation by Cryptococcus neoformans under distinct environmental conditions.Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system.Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV lightVaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models.The Anti-helminthic Compound Mebendazole Has Multiple Antifungal Effects against Cryptococcus neoformans.Magnesium Ion Acts as a Signal for Capsule Induction in Cryptococcus neoformans.Opportunistic fungi and fungal infections: the challenge of a single, general antifungal vaccine.Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma.Methamphetamine enhances Cryptococcus neoformans pulmonary infection and dissemination to the brain.Cryptococcus neoformans constitutes an ideal model organism to unravel the contribution of cellular aging to the virulence of chronic infections.The use of chitosan to damage Cryptococcus neoformans biofilms.Quorum sensing-mediated, cell density-dependent regulation of growth and virulence in Cryptococcus neoformans.Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responsesOur current understanding of fungal biofilms.Pertussis: a matter of immune modulation.Fungal Biofilms: Relevance in the Setting of Human Disease.Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases.Candida species: new insights into biofilm formation.Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.Cryptococcus antigens and immune responses: implications for a vaccine.Innate host defenses against Cryptococcus neoformans.The Extracellular Matrix of Fungal Biofilms.Virulence of Cryptococcus sp. Biofilms In Vitro and In Vivo using Galleria mellonella as an Alternative ModelBiofilm localization in the vertical wall of shaking 96-well plates.Role of a VPS41 homologue in starvation response, intracellular survival and virulence of Cryptococcus neoformans.EDTA inhibits biofilm formation, extracellular vesicular secretion, and shedding of the capsular polysaccharide glucuronoxylomannan by Cryptococcus neoformans.Vesicular transport across the fungal cell wall.Use of a stainless steel washer platform to study Acinetobacter baumannii adhesion and biofilm formation on abiotic surfaces.Characterization of phenotypic switching in Cryptococcus neoformans biofilms.
P2860
Q24657601-4A934CD5-CABC-45F6-BBCF-B7D4FE44600CQ28071716-35F0B13E-E874-4143-AF2D-C1A409C2AF3CQ28087622-C2514E64-996B-4180-A7C0-7458CD4F9CD3Q30487314-AA965169-3588-4DE8-B766-E205BAB43360Q30530667-F331A8D1-22AB-483A-AF5B-144459662ECBQ33326460-5FD85A5D-3D52-42BC-9A26-A4A7F822AC1FQ33505448-7F15D3BA-F8D3-4741-BE1D-C4EEE36D5103Q33755308-8885D1FF-3FA0-495C-8826-CDF1A4CCA8E0Q34509773-850F47E0-2889-4324-99CA-6EDDC166F4E2Q34680558-703FB3E4-EDDF-452C-83A1-52D5BCAB467FQ34764576-0892A747-582E-4A70-AA52-031ECC3E5783Q34781743-18BB4CB3-0DCB-477F-9A6B-9FE6C64DCDA4Q35217511-F0E9D269-50C7-471B-AE28-31FB5C80DF72Q35913297-05E07FB8-04B5-415B-83A8-97A3C7FF732AQ36192774-B9D60049-8325-4DB5-931B-BF853E572841Q36344094-D99ED87B-57FC-487B-BF53-A49AF8403368Q36686273-04628B8C-D5F8-42D3-B307-2E07F42CC837Q36690302-E5C97F9A-E85D-4687-8DD6-F63EBBD7C516Q36914682-64C45582-0B99-4C5B-ADFC-407D9802BB33Q37074706-132604E3-13BB-431F-921B-D382CEC8F7B7Q37126044-F28FABAB-5D42-424B-9A86-1E65782CA95BQ37438897-E83C82AC-B076-48D7-8AD5-1C0E1B136ABBQ37446469-36257E71-E586-4001-8C6C-7651D24A07CCQ37562226-0C43F04F-22E9-4907-AB58-3069EDAB1DA1Q37622959-3B0D6C43-B8E7-4748-8C1A-3616A7481E2AQ37825920-099CBB2E-0DF7-468E-8028-AA03F9B1238FQ37887512-5507C819-73F4-4EFB-BB6F-E6785380AFCEQ38011299-75321AA3-2F01-4E84-A284-3292B4D238ECQ38019018-5D17687B-C486-4520-A7A8-CF17C8A33330Q38154164-C450F186-C06D-40C0-A95B-37516269A1BFQ38155197-E5039E80-CF20-450B-8D2D-1ADC787C3E2DQ38752388-81B82420-F5C9-4239-BC59-E3FCEC816789Q38856993-D8962229-FC44-48B3-B344-590CF7C9A6F6Q38858709-FDD76983-A0A0-44D9-897D-4C858750ABB0Q39192972-C9CFC4AA-4DCD-4EE8-A5D2-F4D3BDDADC15Q40249599-2FFAEA04-3A59-42F0-9666-C07AAD80F11CQ41588074-0E9A8C2A-880E-49CF-B1FD-7C030E32D42AQ41825169-4B11CFE2-8AF2-4374-8D06-EF55191CC35CQ42248142-9C05D0FC-C350-469A-BF17-95CCE134CC00Q43077543-D4B126A5-6319-4034-850B-BA092397C3DD
P2860
Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Specific antibody can prevent ...... ates with protective efficacy.
@en
Specific antibody can prevent ...... ates with protective efficacy.
@nl
type
label
Specific antibody can prevent ...... ates with protective efficacy.
@en
Specific antibody can prevent ...... ates with protective efficacy.
@nl
prefLabel
Specific antibody can prevent ...... ates with protective efficacy.
@en
Specific antibody can prevent ...... ates with protective efficacy.
@nl
P2860
P1476
Specific antibody can prevent ...... ates with protective efficacy.
@en
P2093
Luis R Martinez
P2860
P304
P356
10.1128/IAI.73.10.6350-6362.2005
P407
P577
2005-10-01T00:00:00Z